![]() ![]() Submitted papers should be well formatted and use good English. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). ![]() Please visit the Instructions for Authors page before submitting a manuscript. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI. ![]() A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. All manuscripts are thoroughly refereed through a single-blind peer-review process. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Research articles, review articles as well as short communications are invited. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. All submissions that pass pre-check are peer-reviewed. Manuscripts can be submitted until the deadline. Once you are registered, click here to go to the submission form. ![]() Manuscripts should be submitted online at by registering and logging in to this website. Advances in diagnosis, definition of pathophysiological models, and treatment strategies will be further investigated. Therefore, the aim of the present Special Issue, published in the Journal of Personalized Medicine, is to provide a comprehensive description of the neurological and psychiatric effects of COVID-19. However, despite the efforts made to define, classify, and treat COVID-19-related neuropsychiatric diseases, their characteristic underlying neurobiology remains largely unknown. A steep surge or worsening of neurologic and psychiatric syndromes has been reported during and after SARS-CoV-2 infection, including confusion, depression, anxiety, post-traumatic stress disorder, dementia, and psychosis. Among all the organs involved, the brain is one of the most severely affected. Now, after two years of the pandemic, there is robust evidence documenting that COVID-19 extends beyond the pulmonary system. Since then, the SARS-CoV-2 infection has spread globally. Towards the end of 2019, a new respiratory syndrome, now known as coronavirus disease 2019 (COVID-19), was reported in Wuhan, China. See Privacy Policy at and California Privacy Notice at. We're sharing this interview in celebration of her remarkable life and career. Very sadly, Carla passed away unexpectedly last month after a brief illness. Jovial Foods has since grown into a multi-million dollar brand that includes organic tomatoes, olive oil, and snacks. When that partnership ended in a lawsuit, Carla decided to launch her own brand of pasta, made from gluten-free grains and a prehistoric wheat called Einkorn. They eventually partnered with the Italian company Bionaturae to sell whole wheat pastas, sauces and olive oil in the U.S. She met her husband Rodolfo while studying abroad in Italy and by the early 1990's, the two of them were running a small sandwich shop in Mystic, Connecticut. Carla Bartolucci grew up in an Italian-American household, eating fresh gnocchi and ravioli made by her mother, and lobster caught by her father. ![]()
0 Comments
Leave a Reply. |